Abstract

Hereditary non-polyposis colorectal cancer (HNPCC) is the commonest form of inherited colorectal cancer (CRC) predisposition and by definition describes families which conform to the Amsterdam Criteria or reiterations thereof. In ~50% of patients adhering to the Amsterdam criteria germline variants are identified in one of four DNA Mismatch repair (MMR) genes MLH1, MSH2, MSH6 and PMS2. Loss of function of any one of these genes results in a failure to repair DNA errors occurring during replication which can be most easily observed as DNA microsatellite instability (MSI)—a hallmark feature of this disease. The remaining 50% of patients without a genetic diagnosis of disease may harbour more cryptic changes within or adjacent to MLH1, MSH2, MSH6 or PMS2 or elsewhere in the genome. We used a high density cytogenetic array to screen for deletions or duplications in a series of patients, all of whom adhered to the Amsterdam/Bethesda criteria, to determine if genomic re-arrangements could account for a proportion of patients that had been shown not to harbour causative mutations as assessed by standard diagnostic techniques. The study has revealed some associations between copy number variants (CNVs) and HNPCC mutation negative cases and further highlights difficulties associated with CNV analysis.

Highlights

  • Somewhere between 2% and 5% of all colorectal cancers (CRCs) are classified as hereditary non-polyposis colorectal cancer (HNPCC)

  • We were unable to identify any DNA mismatch repair genes targeted by copy number variants (CNVs) that may contribute to a significant proportion of Hereditary non-polyposis colorectal cancer (HNPCC) patients recruited into this study

  • We did identify several genomic regions that were altered in multiple unrelated HNPCC patients that could potentially be associated with disease risk

Read more

Summary

Introduction

Somewhere between 2% and 5% of all colorectal cancers (CRCs) are classified as hereditary non-polyposis colorectal cancer (HNPCC). Despite the definition of HNPCC up to 50% of clinically tested patients with tumours demonstrating microsatellite instability (MSI), the hallmark phenotype of HNPCC, will fail to have any germline mutation identified in any one of the four MMR genes responsible for LS [7,8,9].

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call